Reliable biomarkers are essential tools for tracking disease course, assessing stage, and predicting progression. They are especially critical for guiding treatment decisions when the risk of severe side effects is high.
Autoantibody biomarkers can reveal predictive signatures, helping identify patients who are likely to respond to treatment—and those who may experience adverse reactions. These insights enable more personalized and safer therapeutic approaches.
Our advanced assays allow for the simultaneous analysis of numerous autoantibody targets, accelerating the discovery and validation of biomarkers with high predictive value. This capability brings us closer to a future of precise, individualized patient care.
